{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:09:46Z","timestamp":1791288586092,"version":"4.3.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1097\/01.gco.0000162178.38231.1d","type":"journal-article","created":{"date-parts":[[2005,3,8]],"date-time":"2005-03-08T04:01:12Z","timestamp":1110254472000},"page":"117-121","source":"Crossref","is-referenced-by-count":6,"title":["HIV in pregnancy"],"prefix":"10.1097","volume":"17","author":[{"given":"Jack","family":"Moodley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens L","family":"Wennberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-3-20210128","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/jama.292.2.219","article-title":"Mother-Infant Rapid Intervention at Delivery (MIRIAD) Study Group. Rapid HIV-1 testing during labour: a multicenter study","volume":"292","author":"Bulterys","year":"2004","journal-title":"JAMA"},{"key":"R3-3-20210128","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00126334-200402010-00008","article-title":"Rapid HIV testing of women in labour: too long a delay","volume":"35","author":"Forsyth","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R4-3-20210128","first-page":"362","article-title":"Acceptability and utilisation of voluntary HIV testing and nevirapine to reduce mother-to-child transmission of HIV-1 integrated into routine clinical care","volume":"94","author":"Urban","year":"2004","journal-title":"S Afr Med J"},{"key":"R5-3-20210128","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/09540120410001683358","article-title":"Factors influencing acceptability of voluntary counselling and HIV-testing among pregnant women in Northern Tanzania","volume":"16","author":"de Paoli","year":"2004","journal-title":"AIDS Care"},{"key":"R6-3-20210128","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/01.AOG.0000129957.35105.d4","article-title":"The effectiveness of a verbal opt-out system for human immunodeficiency virus screening during pregnancy","volume":"104","author":"Breese","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R7-3-20210128","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/135965350400900213","article-title":"Influence of mother and infant zidovudine treatment duration on the age at which HIV infection can be detected by polymerase chain reaction in infants","volume":"9","author":"Prasitwattanaseree","year":"2004","journal-title":"Antivir Ther"},{"key":"R8-3-20210128","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/AAC.48.2.430-436.2004","article-title":"Pediatric AIDS Clinical Trials Group 386 Protocol Team. Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women","volume":"48","author":"Acosta","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R9-3-20210128","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00126334-200312150-00006","article-title":"HIVNET 023 Study Team. Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months","volume":"34","author":"Shetty","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-3-20210128","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10096-003-1058-4","article-title":"Quantitation of human immunodeficiency virus type 1 RNA loads in cervicovaginal secretions in pregnant women and relationship between viral loads in the genital tract and blood","volume":"23","author":"Garcia-Bujalance","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R11-3-20210128","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1086\/381673","article-title":"Effect of prenatal vitamin supplementation on lower-genital levels of HIV type 1 and interleukin type 1 beta at 36 weeks of gestation","volume":"38","author":"Fawzi","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R12-3-20210128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jama.288.2.189","article-title":"Two-dose intrapartum\/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV-1 transmission: a randomized trial","volume":"288","author":"Dorenbaum","year":"2002","journal-title":"JAMA"},{"key":"R13-3-20210128","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1086\/341300","article-title":"Development of resistance mutations in women on standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal HIV-1 transmission: a substudy of pediatric AIDS clinical trials group protocol 316","volume":"186","author":"Cunningham","year":"2002","journal-title":"J Infect Dis"},{"key":"R14-3-20210128","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1097\/00002030-200110190-00006","article-title":"Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)","volume":"15","author":"Eshleman","year":"2001","journal-title":"AIDS"},{"key":"R15-3-20210128","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa041305","article-title":"Perinatal HIV Prevention Trial Group. Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy","volume":"351","author":"Jourdain","year":"2004","journal-title":"N Engl J Med"},{"key":"R16-3-20210128","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1097\/00002030-200307040-00022","article-title":"Selection of resistance mutations in pregnant women receiving zidovudine and lamivudine to prevent HIV perinatal transmission","volume":"17","author":"Giuliano","year":"2003","journal-title":"AIDS"},{"key":"R17-3-20210128","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ajog.2003.09.034","article-title":"Elective cesarean delivery plus short-course lamivudine and zidovudine for the prevention of mother-to-child transmission of human immunodeficiency virus type 1","volume":"190","author":"Panburana","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R18-3-20210128","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00404-002-0374-8","article-title":"Post-operative complications after caesarean section in HIV-infected women","volume":"268","author":"Ferrero","year":"2003","journal-title":"Arch Gynecol Obstet"},{"key":"R19-3-20210128","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00002030-200404090-00011","article-title":"European HIV in Obstetrics Group. Higher rates of post-partum complications in HIV-infected than in uninfected women irrespective of mode of delivery","volume":"18","author":"Fiore","year":"2004","journal-title":"AIDS"},{"key":"R20-3-20210128","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/01.AOG.0000127440.68730.23","article-title":"Risk of birth defects associated with nelfinavir exposure during pregnancy","volume":"103","author":"Covington","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R21-3-20210128","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/01.inf.0000086400.93257.74","article-title":"Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy","volume":"22","author":"Alimenti","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R22-3-20210128","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00002030-200404300-00009","article-title":"Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir","volume":"18","author":"Divi","year":"2004","journal-title":"AIDS"},{"key":"R23-3-20210128","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1097\/00002030-200309260-00006","article-title":"Enquete Perinatale Francaise Study Group. Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants","volume":"17","author":"Le Chenadec","year":"2003","journal-title":"AIDS"},{"key":"R27-3-20210128","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1086\/367898","article-title":"A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1","volume":"187","author":"Moodley","year":"2003","journal-title":"J Infect Dis"},{"key":"R28-3-20210128","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(99)80008-7","article-title":"Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomized trial","volume":"354","author":"Guay","year":"1999","journal-title":"Lancet"},{"key":"R29-3-20210128","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0140-6736(03)14341-3","article-title":"Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial","volume":"362","author":"Jackson","year":"2003","journal-title":"Lancet"},{"key":"R30-3-20210128","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jama.292.2.202","article-title":"Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial","volume":"292","author":"Taha","year":"2004","journal-title":"JAMA"},{"key":"R31-3-20210128","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(03)14538-2","article-title":"Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial","volume":"362","author":"Taha","year":"2003","journal-title":"Lancet"},{"key":"R32-3-20210128","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa033500","article-title":"Perinatal HIV Prevention Trial (Thailand) Investigators. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand","volume":"351","author":"Lallemant","year":"2004","journal-title":"N Engl J Med"},{"key":"R33-3-20210128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00002030-200401230-00017","article-title":"ZVITAMBO Study Group. Timing of mother-to-child transmission of HIV-1 and infant mortality in the first 6 months of life in Harare, Zimbabwe","volume":"18","author":"Zijenah","year":"2004","journal-title":"AIDS"},{"key":"R34-3-20210128","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/00002030-200404090-00012","article-title":"Universal nevirapine upon presentation in labour to prevent mother-to-child HIV transmission in high prevalence settings","volume":"18","author":"Stringer","year":"2004","journal-title":"AIDS"},{"key":"R35-3-20210128","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00002030-200102160-00011","article-title":"Methods of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa","volume":"15","author":"Coutsoudis","year":"2001","journal-title":"AIDS"},{"key":"R36-3-20210128","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00126334-200401010-00011","article-title":"Infant feeding practices of women in a perinatal HIV-1 prevention study in Nairobi, Kenya","volume":"35","author":"Kiarie","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R37-3-20210128","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/108729104322740910","article-title":"Infant feeding practices of HIV-infected and uninfected women in Zimbabwe","volume":"18","author":"Gottlieb","year":"2004","journal-title":"AIDS Patient Care STDS"}],"container-title":["Current Opinion in Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003453-200548030-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:41:11Z","timestamp":1785850871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001703-200504000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.gco.0000162178.38231.1d","relation":{},"ISSN":["1040-872X"],"issn-type":[{"value":"1040-872X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}